Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,842,247
-
Share change
-
-479,747
-
Total reported value
-
$19,520,815
-
Price per share
-
$2.49
-
Number of holders
-
51
-
Value change
-
-$4,215,965
-
Number of buys
-
19
-
Number of sells
-
34
Institutional Holders of APPLIED GENETIC TECHNOL CORP - COM (AGTC) as of Q4 2018
As of 31 Dec 2018,
APPLIED GENETIC TECHNOL CORP - COM (AGTC) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,842,247 shares.
The largest 10 holders included
INTERWEST VENTURE MANAGEMENT CO, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, Vanguard Group Inc, DAFNA Capital Management LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., ALTRINSIC GLOBAL ADVISORS LLC, and AJO, LP.
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.